Proposal of HKFoods Plc’s Shareholders’ Nomination Board to the following Annual General Meeting
Reading Time: 3 minutes HKFoods Plc, Stock Exchange Release 13 January 2025, at 5.45 pm EET The Shareholders’ Nomination Board of HKFoods Plc has prepared proposals on the composition and the remuneration of the Board of Directors to the HKFoods’ 2025 Annual General Meeting. Number
Heimdal and Watsoft Team Up to Strengthen MSP Cybersecurity in France
Reading Time: 2 minutes COPENHAGEN, Denmark, and PARIS, France, January 13, 2025 — Heimdal, a top European cybersecurity company, is teaming up with Watsoft, a French IT distributor focused on Managed Service Providers (MSPs). This partnership will help MSPs in France deal with today’s growing
FISKARS CORPORATION: ACQUISITION OF OWN SHARES 13.01.2025
Reading Time: < 1 minute Stock Exchange Release 13.01.2025 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 13.01.2025 Date 13.01.2025 Exchange transaction Buy Share class FSKRS Amount 2000 Average price/share 14.5861 EUR Highest price/share 14.6200 EUR Lowest price/share
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 13.01.2025
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 13.01.2025 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 13.01.2025 Date 13.01.2025 Exchange transaction Buy Share class ALEX Amount 200 Average price/share 8,8500 EUR Highest
OncoZenge AB has entered into a non-binding agreement with the intention to partner with Molteni Farmaceutici for commercialization of BupiZenge™ in Europe
Reading Time: 3 minutes STOCKHOLM, SWEDEN – January 13, 2025 – OncoZenge AB (publ) (“OncoZenge” or the “Company”), announces that the Company has entered into a non-binding agreement with the intention to partner with pharmaceutical leader Molteni Farmaceutici (“Molteni”) regarding exclusive rights to commercialization of BupiZenge™
Arctic Bioscience – Primary insiders participating in convertible loan facility
Reading Time: 2 minutes Reference is made to the stock exchange release from earlier today, 13th January 2025, regarding new funding, including a convertible loan facility of NOK 15 million. The following primary insiders, or closely related companies to primary insiders, are a part of
SciBase announces outcome of directed issue and preliminary outcome of rights issue
Reading Time: 7 minutes SciBase Holding AB (”SciBase” or the ”Company”) today announces the preliminary outcome of the capital raise, consisting of a rights issue of units of approximately SEK 59.3 million (the “Rights Issue”) and a directed issue of units, deviating from existing shareholders’ preferential
Tele2 announces changes to the Group Leadership Team
Reading Time: 2 minutes Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) announces that Kim Hagberg, Executive Vice President, Chief Operations, will leave her position effective from today. Kim joined Tele2 in 2013 and has held many positions over the
Mandatum plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (Altor Fund Manager AB)
Reading Time: 2 minutes Mandatum Plc, Stock exchange release, 13 January 2025 at 20:00 EET Mandatum plc (Business ID 3355142-3) has received a notification, pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act, that the breakdown of Altor Fund Manager AB’s (registration
#25-9 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market